Author:
Lorusso V,Pollera C.F,Antimi M,Luporini G,Gridelli C,Frassineti G.L,Oliva C,Pacini M,De Lena M
Reference24 articles.
1. Hertel LW, Boder GB, Kroin JS, et al. Evaluation of the antitumor activity of gemcitabine (difluor-2′-deoxy-citidine). Cancer Res 1990, 50, 4417–4422.
2. Abbruzzese JL, Grunewald R, Weeks EA, et al. A phase I clinical, plasma and cellular pharmacology study of gemcitabine. J Clin Oncol 1991, 9, 491–498.
3. Gatzeimer U, Shepherd FA, Le Chevalier T, et al. Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study. Eur J Cancer 1996, 32A, 243–248.
4. Phase II study of gemcitabine in previously treated ovarian cancer patients;Lund;J Natl Cancer Inst,1994
5. Carmichael J, Passinger K, Philip P, et al. Advanced breast cancer: a phase II trial with gemcitabine. J Clin Oncol 1995, 13(11), 2731–2736.
Cited by
261 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献